Ownership history in Drystone LLC · 5 quarters on record
This page tracks every 13F SEC filing in which Drystone LLC reported a position in Pfizer (PFE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 166,022 | +1,129 | +0.7% | 3.72% | $4.1M | $24.49 |
| 2025 Q3 | ADDED | 164,893 | +281 | +0.2% | 3.78% | $4.2M | $24.63 |
| 2025 Q2 | ADDED | 164,612 | +1,924 | +1.2% | 3.66% | $4.0M | $23.03 |
| 2025 Q1 | ADDED | 162,688 | +16,888 | +11.6% | 4.13% | $4.1M | $23.63 |
As of 2025 Q4 — sorted by position size